1.
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.
Muayad Jawad, Loya Asad, Hussain Zain S, Chauhan Muhammad Z, Alsoudi Amer F, De Francesco Ticiana et al.
OphthalmologyAug 202421 citationsCohort Study
GLP-1 agonists significantly lowered glaucoma risk (POAG, ocular hypertension, treatment need) compared to metformin in type 2 diabetics, suggesting potential ocular benefits beyond diabetes management.